NCT05785546 Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
| NCT ID | NCT05785546 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Neuromuscular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 368 participants |
| Start Date | 2025-02-19 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 368 participants in total. It began in 2025-02-19 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Development and validation study of a prognostic score - study of prognostic performance by a prospective longitudinal multicenter cohort spread over 8 centers: 4 for the development cohort and 4 for the validation cohort).
Eligibility Criteria
Inclusion Criteria: * Male or female over the age of 18 * Daily wheelchair user (more than 4 hours per day) * Having a neuromuscular disease such as Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II * Accompanied by an identified medical equipment provider, able to respond to the recommendations of the clinical team * Patient informed and having signed consent. Exclusion Criteria: * Person who already has a seat change or FR prescription at the time of inclusion * Having undergone surgery less than 1 year ago or a fracture * Pregnant or breastfeeding women * Patient under guardianship or curatorship.
Contact & Investigator
Samuel Pouplin, PhD
PRINCIPAL INVESTIGATOR
New technology Platform department, Raymond Poincaré Hospital, APHP
Frequently Asked Questions
Who can join the NCT05785546 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Neuromuscular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05785546 currently recruiting?
Yes, NCT05785546 is actively recruiting participants. Contact the research team at samuel.pouplin@aphp.fr for enrollment information.
Where is the NCT05785546 trial being conducted?
This trial is being conducted at Garches, France.
Who is sponsoring the NCT05785546 clinical trial?
NCT05785546 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Samuel Pouplin, PhD at New technology Platform department, Raymond Poincaré Hospital, APHP. The trial plans to enroll 368 participants.